UFD2 Antibodies

Santa Cruz Biotechnology features a diverse variety of UFD2 monoclonal antibodies for research focused on understanding UFD2's role in cellular processes. UFD2 monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). UFD2, also known as Ubiquitin Fusion Degradation 2, plays a critical role in the ubiquitin-proteasome pathway, which is essential for protein degradation and regulation of cellular homeostasis. By mediating the degradation of misfolded or damaged proteins, UFD2 helps maintain cellular integrity and function. Research has shown that UFD2 significantly influences various biological processes, making it an important focus in studies related to cancer, neurodegenerative diseases, and other conditions where protein homeostasis is disrupted. Understanding UFD2's function can provide valuable insights into cellular protein regulation mechanisms. Investigating UFD2's role in protein degradation pathways may reveal new therapeutic approaches for various diseases. UFD2 research using Santa Cruz Biotechnology monoclonal antibodies continues to advance scientific understanding of protein homeostasis and its impact on human health.